Beijing Strong Biotechnologies,Inc. (SHE:300406)
China flag China · Delayed Price · Currency is CNY
12.69
+0.23 (1.85%)
Nov 2, 2026, 3:04 PM CST

SHE:300406 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Equivalents
587.76539.651,043724.04340.72382.52
Short-Term Investments
-321.488.4152.2325.3310.01
Cash & Short-Term Investments
587.76861.051,131876.24666.05392.53
Cash Growth
-20.98%-23.87%29.08%31.56%69.68%-34.83%
Accounts Receivable
1,0421,0601,1651,1981,039948.99
Other Receivables
9.5210.2214.477.984.84103.76
Receivables
1,0521,0711,1791,2061,1241,053
Inventory
183.36187.11220.68229.74219.65252.01
Other Current Assets
368.0680.8950.2722.556.9343.65
Total Current Assets
2,1912,2002,5812,3342,0671,741
Property, Plant & Equipment
507.65546581.77555.24438.93366.19
Long-Term Investments
72.24678.02597.61472.73300.74397.77
Goodwill
1,4981,4981,6731,6731,6731,673
Other Intangible Assets
47.3756.0657.0860.4965.8373.84
Long-Term Accounts Receivable
-4.596.1126.314.8233.12
Long-Term Deferred Tax Assets
49.0743.4334.6745.8537.7331.33
Long-Term Deferred Charges
1.261.531.922.853.323.33
Other Long-Term Assets
560.825.3228.565.4812.450.66
Total Assets
4,9275,0525,5615,1764,6134,320

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Accounts Payable
44.2451.9369.2981.7137.6547.14
Accrued Expenses
53.0951.2482.82108.2199.7107.35
Short-Term Debt
0.090.060.11-81.04163.46
Current Portion of Long-Term Debt
8.098.4137.912.831.74192.99
Current Portion of Leases
-1.271.461.132.020.73
Current Income Taxes Payable
50.6628.4333.4823.1420.5326.16
Current Unearned Revenue
11.4415.320.2718.9520.5719.43
Other Current Liabilities
41.4214.6632.7961.1334.6950.35
Total Current Liabilities
209.03171.32278.13297.12297.94607.6
Long-Term Debt
1,0861,0641,1241,1271,017766.4
Long-Term Leases
4.064.085.254.911.040.91
Long-Term Unearned Revenue
21.5124.0528.1316.9718.6520.45
Long-Term Deferred Tax Liabilities
4.916.237.138.459.8210.98
Total Liabilities
1,3261,2701,4421,4541,3441,406

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Common Stock
586.14586.31588.33588.45588.84588.98
Additional Paid-In Capital
342.57347.38382.02399.95392.12487.69
Retained Earnings
2,6012,7633,0992,6682,2031,873
Treasury Stock
-54.99-57.84-93.63-109.59-93.07-74.8
Comprehensive Income & Other
131.44148.83149.2177.3179.98-0.54
Total Common Equity
3,6063,7884,1253,7253,2712,874
Minority Interest
-5.55-5.16-5.57-3.04-2.4439
Shareholders' Equity
3,6013,7834,1193,7223,2692,913
Total Liabilities & Equity
4,9275,0525,5615,1764,6134,320

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Total Debt
1,0991,0781,1681,1361,1021,124
Net Cash (Debt)
-510.97-216.67-37.2-259.39-436.45-731.96
Net Cash Growth
------
Net Cash Per Share
-0.87-0.37-0.06-0.44-0.71-1.25
Filing Date Shares Outstanding
585.43596.51537.21559.57568.93588.98
Total Common Shares Outstanding
585.43596.51537.21559.57568.93588.98
Working Capital
1,9822,0282,3032,0371,7691,133
Book Value Per Share
6.166.357.686.665.754.88
Tangible Book Value
2,0612,2342,3951,9921,5331,128
Tangible Book Value Per Share
3.523.754.463.562.691.92
Buildings
-517.58518.07288.33288.33280.47
Machinery
-313.94297.51262.57249.98244.43
Construction In Progress
---211.0374.820.08